FDAHealthNovember 18, 2024
Viatris Inc — Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) 1000-count bottles (NDC 0378-1819-10), Rx only, Manufactured for: Mylan Pharmaceutica
⚠️ Superpotent Drug and Subpotent Drug: potency failures obtained
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- November 18, 2024
Nationwide within the United States and Puerto Rico
What's affected?
- Product
- Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) 1000-count bottles (NDC 0378-1819-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
- Brand
- LEVOTHYROXINE SODIUM
- Lot code
- a)8179847
Additional details
Lot #: a)8179847, Exp. Date July 2025; b) 3203518, Exp. Date July 2025
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 55,032 bottles.
Get Health recall alerts
Delivered to your inbox. Free. No account required.